DNBELAB
LIVE

Serial Number

79297113

Owner

MGI TECH CO., LTD.

Attorney

Charles Ho

Filing Date

Jun 12, 2020

Add to watchlist:

No watchlists yet
View on USPTO

DNBELAB Trademark

Serial Number: 79297113 • Registration: 6430658

DNBELAB is a trademark filed by MGI TECH CO., LTD. on June 12, 2020. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

MGI TECH CO., LTD. (35 trademarks)

Main Building and Second Floor of

Entity Type: 99

Trademark Details

Filing Date

June 12, 2020

Registration Date

July 27, 2021

Published for Opposition

May 11, 2021

Goods & Services

Recorded computer programs for biological data mining; recorded computer programs for developing bioinformatics database for others; recorded computer programs for analyzing genome information; laboratory apparatus and instruments, namely, gene analyzers for genome information; gene amplifier apparatus for laboratory use; laboratory equipment, namely, protein sequence analysis apparatus; apparatus and measuring instruments for physical and chemical test and composition analysis, not for medical purposes, namely, electronic analyzers for testing and analyzing chemical and biological substances for the presence, absence, or quantity of target chemicals, biologics and contaminants; diagnostic apparatus, not for medical purposes, namely, for the detection of pathogens for laboratory or research use; nucleic acid sequencers used for analyzing nucleic acids in scientific research; automatic chromatographic apparatus for laboratory use; data processing apparatus; clothing for protection against accidents, irradiation and fire

Reagents for gene detection for medical purposes; medical diagnostic test reagents for medical genetic characteristics; medical diagnostic reagents; medical diagnostic reagents for the analysis of immune system; diagnostic biomarker reagents for medical purposes; chemical reagents for medical or veterinary purposes; biological preparations for medical purposes; pharmaceutical preparations for treating cancer and genetic diseases; diagnostic reagents for gene detection for veterinary purposes; dietetic substances, namely, food adapted for medical use

Acids; bases being chemical preparations for scientific purposes; diagnostic reagents and preparations, except for medical or veterinary use; metallic oxides; isotopes for industrial purposes; industrial chemicals; diagnostic preparations, other than for medical or veterinary purposes; biochemical catalysts; synthetic resins, unprocessed

Medical diagnostic apparatus for testing DNA and RNA samples for medical purposes; medical apparatus for detecting gene, namely, flow cytometers and flow-based analyzers providing cell and particle analysis detection for medical uses; diagnostic apparatus for medical purposes for testing blood sugar levels, cancer cells and DNA; apparatus for use in medical analysis, namely, computerized medical recording and analysis apparatus for the diagnosis and analysis of cancer, genetic diseases and microbial infectious diseases; medical apparatus and instruments, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; medical apparatus and instruments, namely, apparatus for detecting tumor cancer and genetic diseases; medical apparatus and instruments, namely, apparatus for detecting and treating tumor and cancer; apparatus for the regeneration of stem cells for medical purposes; blood testing apparatus; radiological apparatus for medical purposes; surgical implants comprised of artificial materials

Filing History

CORRECTION UNDER SECTION 7 - PROCESSED
Sep 8, 2022 COC.
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Aug 2, 2022 APRE
TEAS SECTION 7 REQUEST RECEIVED
Mar 3, 2022 ES7R
FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 26, 2021 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Dec 3, 2021 FICS
FINAL DISPOSITION PROCESSED
Dec 3, 2021 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 27, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
Jul 27, 2021 R.PR
NOTIFICATION PROCESSED BY IB
May 11, 2021 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 11, 2021 NPUB
PUBLISHED FOR OPPOSITION
May 11, 2021 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 21, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Apr 21, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 21, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 1, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 16, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 16, 2021 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Mar 16, 2021 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Mar 9, 2021 GNFN
FINAL REFUSAL E-MAILED
Mar 9, 2021 GNFR
FINAL REFUSAL WRITTEN
Mar 9, 2021 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 9, 2021 TEME
REFUSAL PROCESSED BY IB
Dec 7, 2020 RFNT
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 30, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 30, 2020 TROA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Nov 25, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 25, 2020 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 25, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 25, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Nov 25, 2020 COAR
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 18, 2020 RFCS
REFUSAL PROCESSED BY MPU
Nov 17, 2020 RFRR
APPLICATION FILING RECEIPT MAILED
Nov 3, 2020 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 1, 2020 RFCR
NON-FINAL ACTION WRITTEN
Oct 31, 2020 CNRT
ASSIGNED TO EXAMINER
Oct 30, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 30, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 29, 2020 REPR